Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Exact Sciences Corp shares valued at $375,000 were sold by ORVILLE JACOB A on Nov 19 ’25. At $75.00 per share, ORVILLE JACOB A sold 5,000 shares. The insider’s holdings dropped to 23,237 shares worth approximately $2.38 million following the completion of this transaction.
Also, Herriott James sold 1,000 shares, netting a total of over 70,000 in proceeds. Following the sale of shares at $70.00 each, the insider now holds 11,585 shares.
Before that, ORVILLE JACOB A had added 5,000 shares to its account. In a trade valued at $375,000, the Officer bought Exact Sciences Corp shares for $75.00 each.
As published in a research note from Evercore ISI on January 05, 2026, Exact Sciences Corp [EXAS] has been rated down from an Outperform to an In-line and the price target has been revised to $105. Analysts at Mizuho started covering the stock with ‘”an Outperform”‘ outlook in a report released in early April. As of March 13, 2025, RBC Capital Mkts has initiated its “Sector perform” rating for EXAS. Earlier on January 23, 2025, Barclays initiated its rating. Their recommendation was “an Overweight” for EXAS stock.
Analyzing EXAS Stock Performance
On last trading session, Exact Sciences Corp [NASDAQ: EXAS] rose 0.08% to $102.34. The stock’s lowest price that day was $102.29, but it reached a high of $102.465 in the same session. During the last five days, there has been a surge of approximately 0.55%. Over the course of the year, Exact Sciences Corp shares have jumped approximately 88.82%.
Support And Resistance Levels for Exact Sciences Corp (EXAS)
RSI (Relative Strength Index) is 82.75 on the 14-day chart, showing overbought technical sentiment.
Is Exact Sciences Corp subject to short interest?
Stocks of Exact Sciences Corp saw a sharp rise in short interest on 2025-12-31 jumping by 3.44 million shares to 8.54 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 5.1 million shares. A jump of 40.29% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.87 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.87.
Which companies own the most shares of Exact Sciences Corp (EXAS)?
In terms of Exact Sciences Corp share price expectations, FactSet research, analysts set an average price target of 105 in the next 12 months, up nearly 2.68% from the previous closing price of $102.26. Analysts anticipate Exact Sciences Corp stock to reach 105 by 2026, with the lowest price target being 46. In spite of this, 16 analysts ranked Exact Sciences Corp stock as Buy at the end of 2026. On August 28, 2024, Wells Fargo assigned a price target of “an Overweight” to the stock and initiated coverage with a $75.
